The Asia Pacific Cell Expansion Market was valued at USD 1.46 billion in 2016 and is projected to be growing at a CAGR of 21.6%, to touch USD 3.87 billion by 2021.
Cell Expansion is done by the procedure of cloning, which involves the derivation of the state of cells or substances from the same cell or varied multiple sources. The required setting for stem cell expansion is preserved by a combination of various media, reagents and supplements and may also involve the participation of healthy feeder populations or conditioned components taken off feeder cells.
The growth of the Asia Pacific Cell Expansion Market is driven by factors such as the availability of huge population base with the market being essentially untapped at the local level. Other driving factors of the market include the growing frequency of incidence of chronic diseases, rising private sector investments for the development of cell-based products augmented by governmental support for the RandD of cell expansion.
The constraints faced by the growth of the cell expansion market include the requirement of skilled workforce and high-tech instrumentation.
Full report at: www.marketdataforecast.com/market-…sion-market-2667/
The Asia Pacific Cell Expansion Market is segmented on the basis of Product, Cell Type, Application, End User and Geography. Based on Product, the Cell Expansion market is divided into Instruments, Consumables and Disposables.
Consumables include reagents, media and serum, and disposables. The instruments segment consists of cell expansion supporting equipment, bioreactors, and automated cell expansion systems.
The cell expansion supporting equipment segments is segmented into flow cytometer, centrifuges, cell counter, and other supporting equipment. Bioreactors are further classified into micro-carrier bioreactors and perfusion/hollow fibre reactors.
Disposables are further classified into tissue culture flasks, bioreactor accessories, and other disposables.
On the basis of cell type the market is segmented into Human Cells and Animal Stem Cells. The human cells segment is further divided into Human Differentiated stem cells and Human stem cells, with the human stem cells segment further categorised into embryonic stem cells, adult stem cells and induced pluripotent stem cells.
By Application, the cell expansion market is categorised into Regenerative Medicine and Stem Cell Research, and Cancer and Cell Based Research. On the basis of End User, the market is distributed among hospitals, biotech and pharma companies, and academic and research institutes.
The Asia Pacific region is geographically segmented into China, India, Japan, South Korea, and Australia. Factors such as a huge population with consequent increased incidence of chronic diseases, and growing disposable incomes due to emerging economies in countries such as India and China are expected to lead the growth of the market in this region.
Asia Pacific is expected to face a market boom owing to plans by leading companies to tap the vast market, which is reflected in its stout CAGR of more than 21%.
The significant players in the Asia Pacific Cell Expansion Market include Beckman Coulter, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Corning, Inc.
(U.S.), GE Healthcare (U.K.), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT, Inc. (U.S.), and Thermo Fisher Scientific, Inc.
Category: Market Research Publishers and RetailersCompany about: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information:Make an Inquiry about this report HERE!